ATE353651T1 - 3-furylanaloga von toxoflavin als kinaseinhibitoren - Google Patents

3-furylanaloga von toxoflavin als kinaseinhibitoren

Info

Publication number
ATE353651T1
ATE353651T1 AT03763902T AT03763902T ATE353651T1 AT E353651 T1 ATE353651 T1 AT E353651T1 AT 03763902 T AT03763902 T AT 03763902T AT 03763902 T AT03763902 T AT 03763902T AT E353651 T1 ATE353651 T1 AT E353651T1
Authority
AT
Austria
Prior art keywords
sup
compounds
present
kinases
furylan
Prior art date
Application number
AT03763902T
Other languages
English (en)
Inventor
Jean Fernand Armand J Lacrampe
Richard William Connors
Chih Yung Ho
Alan Richardson
Eddy Jean Edgard Freyne
Peter Jacobus Buijnsters
Annette Cornelia Bakker
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE353651T1 publication Critical patent/ATE353651T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03763902T 2002-07-15 2003-07-08 3-furylanaloga von toxoflavin als kinaseinhibitoren ATE353651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02077822 2002-07-15

Publications (1)

Publication Number Publication Date
ATE353651T1 true ATE353651T1 (de) 2007-03-15

Family

ID=30011186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763902T ATE353651T1 (de) 2002-07-15 2003-07-08 3-furylanaloga von toxoflavin als kinaseinhibitoren

Country Status (9)

Country Link
US (1) US7241763B2 (de)
EP (1) EP1523485B1 (de)
JP (1) JP2005534681A (de)
AT (1) ATE353651T1 (de)
AU (1) AU2003251010A1 (de)
CA (1) CA2489790A1 (de)
DE (1) DE60311812T2 (de)
ES (1) ES2282673T3 (de)
WO (1) WO2004007499A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7408839B2 (en) * 2004-09-09 2008-08-05 Siemens Building Technologies, Inc. Distance measurement for wireless building automation devices
US20060063523A1 (en) * 2004-09-21 2006-03-23 Mcfarland Norman R Portable wireless sensor for building control
US7378980B2 (en) * 2004-09-29 2008-05-27 Siemens Building Technologies, Inc. Triangulation of position for automated building control components
US7382271B2 (en) * 2004-09-29 2008-06-03 Siemens Building Technologies, Inc. Automated position detection for wireless building automation devices
AR058277A1 (es) 2005-12-09 2008-01-30 Solvay Pharm Gmbh N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion
US7834178B2 (en) * 2006-03-01 2010-11-16 Bristol-Myers Squibb Company Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
US8093245B2 (en) 2006-12-14 2012-01-10 Lexicon Pharmaceuticals, Inc. 4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use
WO2010072807A2 (en) 2008-12-23 2010-07-01 Fondation Jerome Lejeune Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide
JP5763313B2 (ja) * 2009-09-03 2015-08-12 富山化学工業株式会社 ２−（１−ベンゾチオフェン−５−イル）エタノールの製造法
EP2640386B1 (de) 2010-11-16 2017-01-18 Array Biopharma Inc. Kombination aus checkpointkinase-1-inhibitoren und wee1-kinaseinhibitoren
GB201201314D0 (en) 2012-01-26 2012-03-07 Isis Innovation Composition
WO2014002106A1 (en) * 2012-06-25 2014-01-03 Cadila Healthcare Limited Novel compounds for the treatment of dyslipidemia and related diseases
JP7350759B2 (ja) 2018-02-26 2023-09-26 アルゼキュア ファーマ アーべー ニューロトロフィンに関連する疾患を治療するためのトリアジン誘導体
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
EP3844125A1 (de) 2018-08-31 2021-07-07 Corning Incorporated Verfahren zur herstellung von wabenkörpern mit anorganischen filtrationsabscheidungen
MX2021002442A (es) 2018-08-31 2021-09-21 Corning Inc Métodos para elaborar cuerpos de panal con depósitos de filtración inorgánicos.
CN112142748B (zh) 2019-06-28 2023-07-04 上海医药集团股份有限公司 一种吡唑酮并嘧啶类化合物、其制备方法及应用
MX2021015572A (es) 2019-06-28 2022-04-06 Shanghai Pharmaceuticals Holding Co Ltd Compuesto de pirazolopirimidina, método de preparación para el mismo y sus aplicaciones.
JP2024520969A (ja) 2021-05-28 2024-05-28 江蘇天士力帝益薬業有限公司 Ｗｅｅ１阻害剤とその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039883B (en) * 1979-01-12 1982-12-01 Vnii Antibiotikov Preparation of reumycin
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
JPH09255681A (ja) 1996-03-25 1997-09-30 Taisho Pharmaceut Co Ltd 抗腫瘍剤
KR100850393B1 (ko) * 2000-06-30 2008-08-04 글락소 그룹 리미티드 퀴나졸린 화합물의 제조방법
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Also Published As

Publication number Publication date
EP1523485B1 (de) 2007-02-14
WO2004007499A1 (en) 2004-01-22
US7241763B2 (en) 2007-07-10
JP2005534681A (ja) 2005-11-17
ES2282673T3 (es) 2007-10-16
EP1523485A1 (de) 2005-04-20
CA2489790A1 (en) 2004-01-22
DE60311812D1 (de) 2007-03-29
DE60311812T2 (de) 2007-11-22
AU2003251010A1 (en) 2004-02-02
US20060040943A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
ATE353651T1 (de) 3-furylanaloga von toxoflavin als kinaseinhibitoren
DE60326646D1 (de) Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen
ATE339418T1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
CY1105686T1 (el) 2-(ΠΥΡΙΔΙΝ-2-ΥΛΑΜΙΝΟ)-ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΥΝ-7-ΟΝΕΣ
CY1106933T1 (el) Ενωσεις πυριμιδινης
MX2008005398A (es) Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer.
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
MY153727A (en) Pyridazinone derivatives
DE602004011199D1 (de) 5-phenylthiazolderivate und deren verwendung als p13-kinase-inhibitoren
ATE461179T1 (de) Hemmer der akt aktivität
MX2009013218A (es) Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus.
MY153261A (en) Pyridiazinone derivatives for tumour treatment
TW200608977A (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
MY156407A (en) 5-phenylthiazole derivatives and use as p13 kinase inhibitors
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей
DE602005026509D1 (de) Hemmer der akt aktivität
NZ533310A (en) Benzimidazoles useful as protein kinase inhibitors
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
DE60333387D1 (de) Triazolopyridazine als proteinkinase-inhibitoren
EA200500299A1 (ru) Пиразольные композиции, используемые в качестве ингибиторов gsk-3
CY1111556T1 (el) Παραγωγα 2-βενζυλοπυριδαζινονης ως αναστολεις μετ-κινασης
ATE554087T1 (de) Neue kinaseinhibitoren
BRPI0517737A (pt) inibidores de quinase
MXPA04006271A (es) Derivados de indolinona utiles como inhibidores de la proteina cinasa.
BRPI0512547A (pt) pirimidinas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties